Delights and let‐downs in the management of tumor necrosis factor receptor‐associated periodic syndrome: the canakinumab experience in a patient with a high‐penetrance T50M TNFRSF1A variant

Publisher: John Wiley & Sons Inc

E-ISSN: 1756-185x|18|4|473-475

ISSN: 1756-1841

Source: INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol.18, Iss.4, 2015-05, pp. : 473-475

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content